Journal of Histochemistry and Cytochemistry, Vol. 45, 1493-1502, Copyright © 1997 by The Histochemical Society, Inc.


ARTICLE

Copper-metallothionein in the Kidney of Macular Mice: A Model for Menkes Disease

Mika Suzuki-Kurasakia, Masashi Okabea, and Masaaki Kurasakia
a Department of Environmental Medicine and Informatics, Graduate School of Environmental Earth Science, Hokkaido University, Sapporo, Japan

Correspondence to: Masaaki Kurasaki, Dept. of Environmental Medicine and Informatics, Graduate School of Environmental Earth Science, Hokkaido Univ., Kita 10 Nishi 5, Kita-Ku, Sapporo 060, Japan.


  Summary
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Menkes disease is an X-linked disorder of copper metabolism. Excess amounts of copper in the kidney of Macular mice, a model for this disease, were found as copper-metallothionein (Cu-MT) from kidney of the mice. Histochemical studies of Cu-MT based on its autofluorescent emission properties showed that the protein was predominant in the proximal convoluted tubule (PCT) cells of the cortex. PCT cells are known to be the primary site of the nephrotoxicity caused by heavy metals. MT mRNA was also observed in the cortex, indicating that the protein was biosynthesized in this region. On the basis of these results, we suggest that biosynthesis and degradation of Cu-MT occur repeatedly in the PCT cells of the cortex. We also compared the histochemical localization of Cu-MT in Macular mice and Long-Evans cinnamon rats, a model for Wilson's disease. The significance of this comparison is discussed. (J Histochem Cytochem 45:1493-1501, 1997)

Key Words: copper, metallothionein, Menkes disease, Macular mouse, kidney, in situ blotting, autofluorescence


  Introduction
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Menkes kinky hair disease (Menkes et al. 1962 ) is an X chromosome-linked disorder of copper metabolism characterized by progressive neurological impairment and death in early childhood (Danks et al. 1972 ; Danks et al. 1973 ; Goka et al. 1976 ; Horn et al. 1978 ; Williams and Atkin 1981 ). The kidney and intestinal wall of Menkes patients have a markedly elevated copper content, although the brain, serum, and liver do not receive physiologically adequate amounts of copper. The X-linked mutants of mice are well known models for Menkes disease (Evans and Reis 1978 ; Lott et al. 1979 ; Mann et al. 1979a , Mann et al. 1979b ; Nishimura 1984 ). Clinical, pathological, and chemical features of the mice, including abnormal copper accumulation in the kidney and intestine, correspond to those of patients with Menkes disease to a noticeable degree. Unlike the patients, the mice are able to survive and regain fertility after administration of copper. Therefore, these mutant mice are excellent models in which to study copper metabolism in Menkes disease.

Recently, the gene encoding a P-type, cation-transporting ATPase was shown to be responsible for the decrease in hepatic copper content in Menkes patients (Chelly et al. 1993 ; Mercer et al. 1993 ; Vulpe et al. 1993 ). However, the developmental mechanisms of the abnormal copper accumulation in the kidneys of Menkes patients and mouse models have not been sufficiently investigated.

Copper is an essential trace element that requires a delicate cellular balance between necessary and toxic concentrations. Metallothionein (MT), a low molecular weight heavy metal binding protein, plays an important role in copper homeostasis and detoxification (Kojima and Kägi 1978 ; Kägi and Kojima 1987 ). Because it is generally accepted that surplus copper in the eukaryotic cells is bound to MT, excessive amounts of copper in the renal and intestinal cells of patients with Menkes disease are believed to exist in the form of Cu-MT. Kelly and Palmiter 1996 suggested that MT was essential to protect the embryonic placenta of Menkes disease against copper toxicity.

Hepatic copper accumulation is observed in some other disorders, such as Wilson's disease (Scheinberg and Steinlieb 1984 ). Nakayama et al. 1996 and Sakurai et al. 1992a , Sakurai et al. 1992b , Sakurai et al. 1993 reported that large amounts of Cu-MT are present in the liver of Long-Evans cinnamon (LEC) rats (Li et al. 1991a , Li et al. 1991b ; Okayasu et al. 1992 ), a model for Wilson's disease.

To gain insights into the developmental mechanism of the abnormal copper metabolism, we investigated the histochemical distribution of Cu-MT in the kidney of Macular mice by a method based on the autofluorescent emission properties of thiolate clusters in the protein (Nakayama et al. 1996 ; Okabe et al. 1996 ). Macular mice, discovered by Nishimura 1984 , are a model for Menkes disease. Before the histochemical study, we identified a copper binding protein purified from the kidney of Macular mice as Cu-MT. The elucidation of its distribution in the kidney would greatly benefit understanding of the system for copper transport, storage, reabsorption, and excretion in Menkes disease. We also compared the renal localization of Cu-MT in Macular mice with that previously described by us in LEC rats (Okabe et al. 1996 ). The physiological importance of the difference between the macular mouse and the LEC rat is discussed.


  Materials and Methods
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Materials
Original breeding pairs of the Macular mouse strain were kindly supplied by Dr. M. Nishimura. The C3H male mice used as a control, weighing 20-25 g, were bought from Japan SLC (Hamamatsu, Japan). Both strains of mice were fed MF-4 standard pellets ad libitum (Oriental Yeast; Tokyo, Japan), containing 1.5 mg of copper/100 g, and water, and were housed under conditions of constant temperature (22 ± 1C) and humidity (50 ± 10%). Sephadex G-75, DEAE-Sephadex A-25, Octyl-Sepharose CL-4B, and ProRPC HR5/2 were obtained from Pharmacia LKB Biotechnology (Uppsala, Sweden). Other chemicals were reagent grade. Nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indoryl phosphate (BCIP) were obtained from Sigma (St Louis, MO). Zeta probe membrane and nylon membrane were from Bio-Rad (Richmond, CA) and Pall Ultrafine Filtration (Glen Cove, NY), respectively. The DIG DNA labeling and detection kit was bought from Boehringer Mannheim (Mannheim, Germany).

Copper Therapy of Macular Mice
Copper was administered to the mice by SC injections in the mid-dorsal region of 10 µl of copper chloride solution (10 µg of copper/g bw in 0.9% NaCl) on the morning of postnatal Days 7 and 10. Injections were made with a 10-µl Terumo microsyringe MT-10 (Tokyo, Japan).

Purification of Copper Binding Protein from Kidneys of Macular Mice
Copper binding proteins from 7.5 g of the kidneys were purified by a simple method that we previously described (Suzuki-Kurasaki et al. 1996 ). Briefly, 7.5 g of kidney from Macular mice was homogenized (1:1, w/v) in 50 mM Tris-HCl buffer, pH 8.6, and centrifuged at 9000 x g for 30 min. The fat-free supernatant was subsequently recentrifuged at 100,000 x g for 1 hr. The cytosol was applied to a column (2.5 x 100 cm) of Sephadex G-75 and the fractions were analyzed for metal concentrations with a Hitachi frame atomic absorption spectrophotometer model 180-80 (Hitachi; Tokyo, Japan) and absorbance at 280 nm with a Beckman spectrophotometer model DU-65 (Fullerton, CA).

Further purification of the low molecular weight copper-containing fractions was carried out on a column of DEAE-Sephadex A-25 (2.1 x 4 cm) with a linear gradient. The main copper-containing peak was immediately subjected to a column (1.1 x 3 cm) of Octyl-Sepharose CL-4B. The pass-through fractions were gathered.

Finally, analytical and preparative chromatography was carried out on a reverse-phase FPLC column, ProRPC HR5/2, attached to the fast protein liquid chromatography (FPLC) equipment from Pharmacia LKB Biotechnology. Fractions were collected and measured for absorbance at 220 nm with a Beckman spectrophotometer model DU-50 and for copper content with a Hitachi flameless atomic absorption spectrophotometer model 170-70. The isolated protein was lyophilized. All steps were performed at 4C.

Amino Acid Analysis
The proteins were oxidized with performic acid at 4C for 16 hr and dried with a Yamato rotary evaporator model RE-40 (Tokyo, Japan) at 40C. Amino acid analysis after hydrolysis at 110C with 6 N HCl for 24 hr was performed on a Hitachi amino acid analyzer model 305.

Histochemical Observation of Luminescence from Cu-MT
All procedures were carried out according to the methods of Okabe et al. 1993 , with some modifications. Zeta probe membranes were used to observe the overall kidney and glass slides were used for the microscopic observations of the fluorescent signal of Cu-MT (section thickness: membrane blotting 20 µm; glass slides 5µm). Membrane blotting was processed according to the method of Okabe et al. 1993 . Briefly, tissues removed from animals perfused transcardially were frozen and cut with a cryostat microtome. The sections were mounted on dry Zeta probe membranes in a cryostat box and thawed at 25C. The membranes were incubated on filter paper pre-wetted with a 40 mM Tris-HCl buffer, pH 8.0, for 10 min at 4C. After the transfer, the tissues were removed by a high-pressure jet spray. Tissue-mounted glass slides were immersed in 70% ethanol.

The fluorescent emissions of Cu-MT were visualized and photographed by using an Olympus BX-50-FLA (Tokyo, Japan) biological microscope system with U-MWU filter cube (DM-400 dichroic mirror, 330-385-nm excitation filter, 530-nm barrier filter) (Tokyo, Japan) with a 100-W mercury lamp as a UV light source. The Cu-MT on the Zeta probe nylon membrane was visualized by illumination with a UV light (365 nm).

Northern Hybridization
To examine the genomic expression of Cu-MT in the kidney, the distribution of mRNA encoding MT was observed according to the method of Sato et al. 1996 . A cDNA fragment of 450 base pairs, including a full length of the rat MT-I coding region, was fractionated by polyacrylamide gel electrophoresis and used as a probe. The coding region of rat MT-I was labeled with DIG-11-dUTP by a random-primed DNA labeling method (Sambrook et al. 1989 ). Renal sections (20 µm) were blotted onto the nylon membranes by the method of Okabe et al. 1993 . The nylon membrane blotted with a renal section was hybridized by the method of Sambrook et al. 1989 , and the signals were detected according to the instruction manual for the DIG DNA labeling and detection kit. All molecular biological techniques were performed by the methods of Sambrook et al. 1989 .

Histochemical Study with Acid Phosphatase
The histochemical distribution of acid phosphatase was investigated by the method of Gossrau et al. (1978), using BCIP as a substrate. The incubation with 0.5 mM BCIP, 0.5 mM NBT, and 45 mM dimethylformamide in 40 mM CH3COOH and 100 mM CH3COONa was carried out at 25C for 60 min.


  Results
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Treatment of Macular Mice
Because some investigators have reported that a single dose of copper at 7th days after birth permitted the mutant mice to survive, we injected copper (10µg of copper/kg bw) into the mice at Days 7 and 10 after birth and compared their survival rates (Table 1). We found that mutant mice injected twice with copper had higher longterm survival rates than mice that received a single injection. The significant difference of the survival rates between two groups of mice receiving one or two injections was observed (p<0.005) by {chi}2 study. Other studies used single injections (Mann et al. 1979b ; Nagara et al. 1981 ; Chelly et al. 1993 ) and two injections (Suzuki and Nagara 1981 ; Kodama et al. 1993 ).


 
View this table:
[in this window]
[in a new window]
 
Table 1. Survival rate of Macular mice

Purification of Low Molecular Weight Copper Binding Protein from Kidneys of Macular Mice
Figure 1A and Figure 1B show representative elution patterns of Sephadex G-75 chromatography of the kidney extracts from Macular mice and control mice, respectively. No peak corresponding to the low molecular weight protein (Peak A) in the chromatogram of Macular mice can be detected in the chromatogram of the control mice. The Kd value of Peak A is 0.76, which agreed well with that of MT from the liver of rats reported by Winge and Miklossy 1982 . Peak A was directly applied to a column of DEAE-Sephadex A-25 (Figure 1C). Copper binding proteins in the major peak from anion-exchange chromatography were found in the pass-through fraction of Octyl-Sepharose chromatography.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 1. Sephadex G-75 chromatography of the renal cytosol of Macular mice (A) and control mice (B). Experimental conditions are described in Materials and Methods. DEAE-Sephadex A-25 chromatography of the low molecular weight copper-containing fraction (Peak A) (C). Copper-containing fractions from elution volume 380-440 ml were pooled and directly applied to a column of Octyl Sepharose CL-4B. Reverse-phase FPLC of the pooled fraction from Octyl Sepharose CL-4B chromatography (D). (A-C) {bullet}, copper content; {circ}, zinc content; {bigtriangleup}, absorbance at 280 nm; - - -, Tris gradient. (D) {bullet}, copper content; --, absorbance at 220 nm; - - -, acetonitrile gradient.

The final purification step of the protein was carried out by FPLC on a reverse-phase ProRPC column (Figure 1D). One copper-containing peak was eluted at a retention time of 8.5 min, the same as the retention time of Cu-MT from the livers of copper-injected rats (Suzuki-Kurasaki et al. 1996 ).

Amino Acid Composition
Table 2 lists the amino acid composition of the copper binding protein obtained by FPLC. Typically for mammalian MTs, the protein showed a high cysteine content and completely lacked aromatic amino acids and histidine. The composition agreed with that deduced from the cDNA sequence of MT (Huang et al. 1977 ). The copper binding protein in the Macular mouse kidney was identified as Cu-MT.


 
View this table:
[in this window]
[in a new window]
 
Table 2. Amino acid composition of Cu-MT from the Macular mouse kidney compared with the composition deduced from the cDNA sequence of mouse MT-I (Schmid et al. 1993 )a

Overall Localization of Cu-MT
We examined the overall histochemical localization of Cu-MT in the kidney of Macular mice by direct autofluorescent observation (Okabe et al. 1993 ; Nakayama et al. 1996 ) based on fluorescent emissions yielded by Cu+-thiolate clusters in Cu-MT (Beltramini et al. 1987 ; Stillman et al. 1989 ). Fluorescent signals were observed in the cortex of the kidney (Figure 2A). The kidney of the control mouse did not exhibit fluorescent signals (Figure 2B). We have proved that the fluorescence is essentially attributable to Cu-MT (Okabe et al. 1993 ; Nakayama et al. 1996 ), although the specificity of the histochemical detection of copper or MT by other several analytical methods has been conflicting (Elmes et al. 1987 ; Williams et al. 1989 ; Schmid et al. 1993 ).



View larger version (90K):
[in this window]
[in a new window]
 
Figure 2. Histochemical distribution of Cu-MT. Renal sections from Macular mice (A) and control mice (B) are illuminated with UV light (365 nm). (A) Bright white regions represent fluorescence of Cu-MT. (B) Renal section indicates no signals under UV excitation. Northern hybridization of the kidney from the Macular mice (C) and the control mice (D) using a labeled MT-I cDNA as a probe. Bar = 5 mm. (E-H) Detailed localization of the fluorescent signals of Cu-MT. Cu-MT is expressed as a yellow signal in the tissue, and the protein is predominantly detected in the PCT cells of the cortex (E). No signals for Cu-MT are detected in the control mouse kidney (F). Granular yellow signals of Cu-MT can be seen in the PCT cells of the cortex (black arrows), and cytosol of some PCT cells exhibits signals for Cu-MT (white arrows) (G). Yellow granular forms of Cu-MT can be seen (black arrows) (H). Signals are also observed in the nuclei of the cells (white arrows) (H). Cu-MT signal and acid phosphatase activity are observed in the same renal section. Acid phosphatase activity (I) and yellow signals of Cu-MT (J) localize together in the PCT cells of the same section of the kidney. Arrows indicate both activities in the granules. Localization of Cu-MT in the cortex region from the LEC rats (K). Histochemical observation on the LEC rats was performed as previously described (Okabe et al. 1996 ). Granular yellow signals for Cu-MT can be seen in the cortex (white arrows) and orange signals can be seen in the outer stripe of outer medulla (black arrows). Bar = 50 µm.

Expression of MT mRNA
The expression of MT mRNA was investigated to determine whether Cu-MT in the cortex was biosynthesized in the kidney or transported from other tissues (Figure 2C and Figure 2D). A high level of mRNA was expressed throughout the renal cortex. The expression of MT mRNA was not detected in the renal medulla and pelvis of the mutant mice. The kidneys of the control mice did not exhibit expression of MT mRNA. Both MT mRNA and its transcripts were detected in the renal cortex of Macular mice, indicating that biosynthesis of MT occurred in this region.

Microscopic Observation of Fluorescence from Cu-MT
To determine the detailed localization of Cu-MT in the kidney, microscopic observation was carried out. In the Macular mice, yellow fluorescence was observed exclusively in the proximal convoluted tubules (PCT) of the cortex (Figure 2E). The renal proximal tubules are the most sensitive sites in kidneys exposed to large doses of heavy metals (Dorian et al. 1992 ). No fluorescence was observed in the glomeruli, Bowman's capsules, and the distal tubules (data not shown). Fluorescent emissions were not observed in the renal cortex (Figure 2F), medulla, and pelvis (data not shown) of the control mouse, even by microscopic observation.

To clarify the subcellular distribution of Cu-MT in the PCT cells, the mechanism of the renal damage caused by copper was investigated. Strong emission signals of spherical granules (Figure 2G and Figure 2H) indicated that Cu-MT was concentrated in certain organelles, such as the lysosomes. Emissions from Cu-MT appeared also in the cytoplasm (Figure 2G) and in some nuclei of the PCT cells (Figure 2H). It has been reported that MT bound heavy metals present in nuclei (Sakurai et al. 1993 ; Tohyama et al. 1993 ; Cherian 1994 ; Suzuki et al. 1994 ).

In the quenching test of the blot, the fluorescent emission disappeared after soaking in 1 mM HgCl2 (data not shown) as we described previously (Okabe et al. 1996 ; Nakayama et al. 1996 ). Therefore, the specificity of the fluorescent detection of Cu-MT was verified.

Localization of Acid Phosphatase
To confirm that Cu-MT exists mainly in the lysosomes, we investigated the histochemical localization of acid phosphatase in the PCT cells. This enzyme is recognized as a histochemical marker for lysosomes (Gossrau 1978 ). Yellow signals of Cu-MT (white arrows in Figure 2J) showed acid phosphatase activity (black arrows in Figure 2I) in the same section of the kidney, suggesting that Cu-MT is highly concentrated in the lysosomes.

Microscopic Observation of Fluorescence from Cu-MT in LEC Rat Kidney
LEC rats are a model for Wilson's disease. Copper and Cu-MT were abnormally accumulated in LEC kidneys. To compare the localization of the fluorescence from Cu-MT in Macular mouse kidney with that in LEC rat kidney, microscopic observation of the fluorescence from Cu-MT was carried out. Orange autofluorescence from Cu-MT was detected in the outer stripe of outer medulla and yellow signals from Cu-MT were observed in the PCT cells of the renal cortex of LEC rat (Figure 2K) as previously described (Okabe et al. 1996 ).


  Discussion
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Menkes disease is a disorder of copper metabolism (Menkes 1962). Accumulation of abnormal amounts of copper in the kidney and intestinal wall of patients and in mouse models of disease is a significant feature. This study showed that excess amounts of copper were present as Cu-MT in the kidney of Macular mice. The properties of Cu-MT autofluorescence enabled us to observe the histochemical localization of the protein directly, as previously described (Nakayama et al. 1996 ; Okabe et al. 1996 ). We verified that the fluorescent emission obtained was from Cu-MT. In the kidney of Macular mice, Cu-MT was found in the lysosomes, cytoplasm, and nuclei of the PCT cells in the cortex. Because both Cu-MT and MT mRNA were observed in the cortex, these data suggest that Cu-MT in the cortex is biosynthesized in this region.

There have been few reports on the direct identification of Cu-MT from the tissues of Menkes patients or from model animals for Menkes disease. Many investigators have believed that the low molecular weight protein associated with Menkes disease is Cu-MT because of its features, e. g., the metal (Chan et al. 1978 ; Onishi et al. 1981 ) and cysteine contents (Prins et al. 1981; Crane and Hunt 1983 ). Our study confirmed the view of earlier studies that Cu-MT is present in Menkes patients and in animal models for Menkes disease. We successfully purified a copper binding protein from the model mice by a method established previously (Suzuki-Kurasaki et al. 1996 ) and identified it as Cu-MT.

Microscopic studies of the detailed localization of Cu-MT showed that it is dominant in the PCT cells of the cortex in Macular mice (Figure 2E). It has been reported that after copper administration Cu-MT accumulates mainly in the renal PCT cells (Williams et al. 1989 ; Evering et al. 1990 ; Schmid et al. 1993 ). The physiological significance of this result is noteworthy, because Foulkes et al. (1978) reported that Cd-MT bound to the brush border of the PCT cells after glomerular filtration. PCT cells are considered to be the primary site of the nephrotoxicity caused by heavy metals, such as cadmium (Foulkes 1978 ; Onishi et al. 1981 ).

The subcellular distribution of Cu-MT in the PCT cells of Macular mice showed a large concentration in lysosomes (Figure 2E). This result coincides with the evidence of Evering et al. 1990 that Cu-MT is incorporated into the lysosomes in the copper-loaded rat kidney. Both the cytosol and nuclei of the PCT cells of Macular mice showed emissions from Cu-MT (Figure 2G and Figure 2H). Because Cu-MT diffuses in the cytoplasm, the emission intensity in the cytoplasm could be relatively sparse. We confirmed that the cytoplasm contained Cu-MT because we purified Cu-MT from the cytoplasm of the kidneys of Macular mice. The localization of Cu-MT in Macular mouse kidney is similar to that observed in the copper-loaded rat kidney (Evering et al. 1990 ). Kodama et al. 1993 demonstrated that copper ions in the PCT cells of Macular mice were found in the organelle-free cytoplasm. The distribution of copper ions in the PCT cells of Macular mice did not correspond to the distribution of Cu-MT, which is consistent with the finding of another study that there is some difference in the histochemical behavior of free copper ions and the copper of Cu-MT (Schmid et al. 1993 ).

Some studies (Squibb et al. 1979 ; Cain and Holt 1983 ; Dorian et al. 1992 ) found that cadmium ions were released from Cd-MT intracellularly by the lysosomal degradation. Therefore, it is believed that Cu-MT in the PCT cells of Macular mice is involved in lysosomal degradation. The significance of the histochemical localization of Cu-MT in Macular mice is not completely clear, but our study on the mRNA expression extends the notion that the biosynthesis and degradation of Cu-MT occur repeatedly by lysosomal degradation. Both Cu-MT and MT mRNA were found in the renal cortex of the Macular mouse, suggesting that Cu-MT is continually synthesized in this region. That is, free copper ions are released from Cu-MT by lysosomal degradation in the PCT cells and are reabsorbed by these cells, especially in the S1 and S2 segments. The released copper ions induce MT mRNA to newly synthesize the protein. However, the newly synthesized Cu-MT was also degraded in lysosomes in the same region. Trace amounts of yellow fluorescence from Cu-MT were observed in the S3 segment of the proximal straight tubules (PSTs), because copper ions are scarcely reabsorbed in the S3 segment owing to the axial heterogeneity of the reabsorption system in the proximal tubules. Our observations suggest that Cu-MT and/or released copper ions were accumulated in the PCT cells. The consideration is supported by the theory of a lysosomal system for Cd-MT described by Nordberg and Nordberg 1987 .

Whereas orange fluorescent emissions were observed in the S3 segment in the kidney of LEC rats (Figure 2K), yellow fluorescence appeared in the PCT cells of Macular mice. Emissions of a model complex of Cu-MT changed from orange to yellow according to a decrease in the molar ratio of copper to thiol (Elmes et al. 1987 ). We believe that the shortwave yellow signals from the protein indicate the oxidation of Cu-MT and that the release of copper ions from the protein results in a decrease in the ratio of copper to thiol. Yellow fluorescence suggests that the protein is in the degradation process.

LEC rats are an inbred strain. These animals exhibit an abnormal accumulation of copper in tissues and die because of the hepatotoxicity induced by copper accumulation; (Li et al. 1991a , Li et al. 1991b ; Okayasu et al. 1992 ). It is interesting to compare the histochemical distribution of Cu-MT in Macular mice with that in LEC rats. As shown in Figure 2K, orange autofluorescence from Cu-MT was observed in the outer stripe of the outer renal medulla and yellow signals were detected in the PCT cells of the renal cortex of the LEC rat. The change in emission color was assumed to be caused by the partial release of copper ions, suggesting oxidation of Cu-MT in lysosomes in the LEC renal cortex. A high level of MT mRNA was expressed in the outer stripe of the outer renal medulla but not in the cortex (Okabe et al. 1996 ; and data not shown), unlike in the Macular mouse. These results suggest that the Cu-MT in the outer stripe of the outer renal medulla of the LEC rat is biosynthesized in this region (Okabe et al. 1996 ). The Cu-MT observed in the renal cortex of the LEC rat has been believed to be transported from other organs by a certain mechanism, to be taken up by the PCT cells after glomerular filtration, and to be degraded in lysosome in the region (Okabe et al. 1996 ). In our study, the expression of mRNA in the renal cortex of the Macular mouse suggests that the Cu-MT in the cortex is biosynthesized and that copper, but not Cu-MT, is transported by a certain carrier, such as albumin in the bloodstream, to the kidney. Copper ions released from the Cu-MT in the renal cortex of the LEC rat were believed to induce Cu-MT in the outer stripe of the outer renal medulla (Okabe et al. 1996 ). However, in Macular mice Cu-MT was not found in the outer stripe of the outer renal medulla, suggesting that the copper ions released from the Cu-MT in the cortex did not induce Cu-MT in the outer stripe of the outer renal medulla. These observations supported the consideration that a lysosomal cycle releasing copper ions from Cu-MT repeatedly contributes to the synthesis of Cu-MT in the cortex.

The apparent discrepancy in copper-transporting systems between Menkes disease and Wilson's disease may be due to the candidate genes for these conditions. Two types of P-type cation-transporting ATPases encoded by an X chromosome-linked gene have been reported to be concerned with copper metabolism: one is a copper-efflux pump (ATP7A) (Camakaris et al. 1995 ), which is a candidate gene for Menkes disease (Chelly et al. 1993 ; Mercer et al. 1993 ; Vulpe et al. 1993 ), and the other (ATP7B) is an enzyme suggested to be responsible for Wilson's disease (Bull et al. 1993 ; Petrukhin et al. 1993 ). These two distinct P-type cation-transporting ATPases showed a 60% homology of their amino acid sequences. In normal organisms, it is believed that copper ions are reabsorbed into PCT cells and that the reabsorbed copper ions are then released into the veins. In the kidney of Macular mice, it was postulated that the efflux function of the ATP7A was subject to a hereditary form of damage and that the copper was accumulated in the PCT cells in the renal cortex. Then, the copper ions bound to Cu-MT repeatedly contributed to the synthesis of Cu-MT in the cortex. Recently, ATP7A was reported to be present in the Golgi apparatus (Petris et al. 1996 ; Yamaguchi et al. 1996 ) and was continuously recycled between the Golgi and the plasma membrane (Petris et al. 1996 ). The lysosomal recycling of Cu-MT in the renal cortex of the Macular mouse might be caused by a dysfunction of ATP7A in the Golgi apparatus.

We have identified Cu-MT in the kidney of Macular mice, and we suggest that Cu-MT is biosynthesized in the renal cortex. Localization of Cu-MT in the kidney of these mice has been also confirmed. These findings, including the lysosomal cycle postulated here, give some clues to future studies on the mechanism of the abnormal copper accumulation in Menkes disease.


  Acknowledgments

We are grateful to Dr M. Nishimura, Institute for Experimental Animals, Hamamatsu University of Medicine, Hamamatsu, Japan, who provided us with a breeding pair of Macular mice, and to Prof Yutaka Kojima, Graduate School of Environmental Earth Science, Hokkaido University, for suggestions and discussion during this study.

Received for publication December 9, 1996; accepted May 29, 1997.


  Literature Cited
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Beltramini M, Münger K, Germann UA, Lerch K (1987) Luminescence emission from the Cu(I)-thiolate complex in metallothioneins. Experientia (suppl 52):237-241 [Medline]

Bull PC, Thomas GR, Romens JM, Forbes JR, Cox DW (1993) The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nature Genet 5:327-337 [Medline]

Cain K, Holt DE (1983) Studies on cadmium-thionein (Cd-MT) induced nephropathy: time course of cadmium-thionein uptake and degradation. Chem Biol Interact 43:223-237 [Medline]

Camakaris J, Petris MJ, Bailey L, Shen P, Lockhart P, Glover TW, Barcroft C, Patton J, Mercer JFB (1995) Gene applification of the Menkes (MNK: ATP7A) P-type ATPase gene of CHO cells is associated with copper resistance and enhanced copper efflux. Hum Mol Genet 4:2117-2123 [Abstract]

Chan W, Garnica AD, Rennert OM (1978) Metal-binding studies of metallothioneins in Menkes kinky hair disease. Clin Chim Acta 88:221-228 [Medline]

Chelly J, Tumer Z, Tonnesen T, Petterson A, Ishikawa-Brush Y, Tommerup N, Horn N, Monaco AP (1993) Isolation of a candidate gene for Menkes disease which encodes for a potential heavy metal binding protein. Nature Genet 3:14-19 [Medline]

Cherian MG (1994) The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells. Environ Health Perspect 102 (suppl 3):131-135[Medline]

Crane IJ, Hunt DM (1983) A study of intestinal copper binding proteins in mottled mice. Chem Biol Interact 45:113-124 [Medline]

Danks DM, Cartwright E, Stevens BJ, Townley RRW (1973) Menkes' kinky hair disease: further definition of the defect in copper transport. Science 179:1140-1142 [Medline]

Danks DM, Stevens BJ, Campbell PE, Gillespie JM, Walker-Smith J, Blomfield J, Turner B (1972) Menkes' kinky-hair syndrome. Lancet 1:1100-1102 [Medline]

Dorian C, Gattone VH II, Klaassen CD (1992) Accumulation and degradation of the protein moiety of cadmium-metallothionein (CdMT) in the mouse kidney. Toxicol Appl Pharmacol 117:242-248 [Medline]

Elmes ME, Clarkson JP, Jasani B (1987) Histochemical demonstration of immunoreactive metallothionein in rat and human tissues. Experientia (suppl 52):533-537 [Medline]

Evans GW, Reis BL (1978) Impaired copper homeostasis in neonatal male and adult female brindled (Mobr) mice. J Nutr 108:554-560 [Medline]

Evering WE, Haywood S, Elmes ME, Jasani B, Trafford J (1990) Histochemical and immunocytochemical evaluation of copper and metallothionein in the liver and kidney of copper-loaded rats. J Pathol 160:305-312 [Medline]

Foulkes EC (1978) Renal tubular transport of cadmium-metallothionein. Toxicol Appl Phamacol 45:505-512 [Medline]

Goka TJ, Stevenson RE, Hefferan PM, Howell RR (1976) Menkes disease: a biochemical abnormality in cultured human fibroblasts. Proc Natl Acad Sci USA 73:604-606 [Abstract]

Gossrau R (1978) Azoindoxylverfahren zum Hydrolasennachweis. Histochemistry 57:323-342 [Medline]

Horn N, Hedron K, Damsgaard E, Tygstrup I, Vestermark S (1978) Is Menkes syndrome a copper storage disorder? Clin Genet 14:186-187[Medline]

Huang IY, Yoshida A, Tsunoo H, Nakajima H (1977) Mouse liver metallothioneins. J Biol Chem 252:8217-8221 [Abstract]

Kägi JHR, Kojima Y (1987) Chemistry and biochemistry of metallothionein. Experientia (suppl 52):25-61 [Medline]

Kelly EJ, Palmiter RD (1996) A murine model of Menkes disease reveals a physiological function of metallothionein. Nature Genet 13:219-222 [Medline]

Kodama H, Abe T, Takama M, Takahashi I, Kodama M, Nishimura M (1993) Histochemical localization of copper in the intestine and kidney of Macular mice: light and electron microscopic study. J Histochem Cytochem 41:1529-1535 [Abstract/Free Full Text]

Kojima Y, Kägi JHR (1978) Metallothionein. Trends Biochem Sci 3:90-93

Li Y, Togashi Y, Sato S, Emoto T, Kang JH, Takeichi N, Kobayashi H, Kojima Y, Une Y, Uchino J (1991) Spontaneous hepatic copper accumulation in LEC rats with hereditary hepatitis: a model of Wilson's disease. J Clin Invest 87:1858-1861 [Medline]

Li Y, Togashi Y, Sato S, Emoto T, Kang JH, Takeichi N, Kobayashi H, Kojima Y, Une Y, Uchino J (1991) Abnormal copper accumulation in noncancerous and cancerous liver tissues of LEC rats developing hereditary hepatitis and spontaneous hepatoma. Jpn J Cancer Res 82:490-492 [Medline]

Lott IT, Dipaolo R, Raghavan SS, Clopath P, Milunsky A, Robertson WC, Kanfer JN (1979) Abnormal copper metabolism in Menkes' steely-hair syndrome. Pediat Res 13:845-850 [Abstract]

Mann JR, Camakaris J, Danks DM, Walliczek EG (1979) Copper metabolism in Mottled mouse mutants. Biochem J 180:605-612 [Medline]

Mann JR, Camakaris J, Danks DM (1979) Copper metabolism in Mottled mouse mutants. Biochem J 180:613-619 [Medline]

Menkes JH, Alter M, Steigleder GK, Weakley DR, Sung JH (1962) A sex-linked recessive disorder with retardation of growth, peculiar hair and focal cerebral and cerebellar degeneration. Pediatrics 29:764-779 [Abstract]

Mercer JFB, Livingston J, Hall B, Paynter JA, Begy C, Chandrasekharappa S, Lockhart P, Grimes A, Bhave M, Siemieniak D, Glover TW (1993) Isolation of a partial candidate gene for Menkes disease by positional cloning. Nature Genet 3:20-25 [Medline]

Nagara H, Yajima K, Suzuki K (1981) The effect of copper supplementation on the brindled mouse: a clinico-pathological study. J Neuropathol Exp Neurol 40:428-446 [Medline]

Nakayama K, Okabe M, Aoyagi K, Yamanoshita O, Okui T, Ohyama T, Kasai N (1996) Visualization of yellowish-orange luminescence from cuprous metallothioneins in liver of Long-Evans Cinnamon rat. Biochim Biophys Acta 1289:150-158 [Medline]

Nishimura M (1984) Model animals for Menkes disease. Pediatr MOOK 33:150-163 (in Japanese)

Nordberg M, Nordberg GF (1987) On the role of metallothionein in cadmium induced renal toxicity. Experientia (suppl 52):669-675 [Medline]

Okabe M, Nakayama K, Kurasaki M, Yamasaki F, Aoyagi K, Yamanoshita O, Sato S, Okui T, Ohyama T, Kasai N (1996) Direct visualization of copper-metallothionein in kidney of LEC rat: application of autofluorescence signal of copper-thionein cluster. J Histochem Cytochem 44:865-873 [Abstract/Free Full Text]

Okabe M, Nyakas C, Buwalda B, Luiten PGM (1993) In sites blotting: a novel method for direct transfer of native proteins from sectioned tissue to blotting membrane: procedure and some applications. J Histochem Cytochem 41:927-934 [Abstract/Free Full Text]

Okayasu T, Tochimaru H, Hyuga T, Takahashi T, Takekoshi Y, Li Y, Togashi Y, Takeichi N, Kasai N, Arashima S (1992) Inherited copper toxicity in Long Evans cinnamon rats exhibiting spontaneous hepatitis: a model of Wilson's disease. Pediatr Res 31:253-257 [Abstract]

Onishi T, Suzue J, Nishikawa K, Muramatsu M, Miyao M (1981) Nature of copper and zinc compounds in tissues from a patient with Menkes kinky hair syndrome. Eur J Pediatr 137:17-21 [Medline]

Petris MJ, Mercer JFB, Culvenor JG, Lockhart P, Gleeson PA, Camakaris J (1996) Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. EMBO J 15:6084-6095 [Abstract]

Petrukhin K, Fisher SG, Pirastu M, Tanzi RE, Chernov I, Devoto M, Brzustowicz LM, Cayanis E, Vitale E, Russo JJ, Matseoane D, Boukhgalter B, Wasco W, Figus AL, Loudianos J, Cao A, Sternlieb I, Evgrafov O, Parano E, Pavone L, Warburton D, Ott J, Penchaszadeh GK, Scheinberg IH, Gilliam TC (1993) Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nature Genet 5:338-343 [Medline]

Prins HW, Van den Hamer CJA (1981) Degradation of S-labeled metallothionein in the liver and the kidney of brindled mice: model for Menkes' disease. Life Sci 28:2953-2959 [Medline]

Sakurai H, Fukudome A, Tawa R, Kito M, Takeshima S, Kimura M, Otaki N, Nakajima K, Hagino T, Kawano K, Hirai S, Suzuki S (1992) Unusual accumulation of copper related to induction of metallothionein in the liver of LEC rats. Biochem Biophys Res Commun 184:1393-1397 [Medline]

Sakurai H, Kamada H, Fukudome A, Kito M, Takeshima S, Kimura M, Otaki N, Nakajima K, Kawano K, Hagino T (1992) Copper metallothionein induction in the liver of LEC rats. Biochem Biophys Res Commun 185:548-552 [Medline]

Sakurai H, Nakajima K, Kamada H, Satoh H, Otaki N, Kimura M, Kawano K, Hagino T (1993) Copper metallothionein distribution in the liver of Long-Evans cinnamon rats: studies on immunohistochemical staining, metal determination, gel filtration and electron spin resonance spectroscopy. Biochem Biophys Res Commun 192:893-898 [Medline]

Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press

Sato S, Okabe M, Kurasaki M, Kojima Y (1996) Metallothionein in the ovaries of laying hens exposed to cadmium. Life Sci 58:1561-1567 [Medline]

Scheinberg IH, Steinlieb I (1984) Wilson Disease. Philadelphia, WB Saunders

Schmid KW, Morgan JM, Öfner D, Hittmair A, Haywood S, Jasani B (1993) Quantitative immunohistochemical evaluation by image analysis of metallothionein in copper-loaded rat kidney. J Histochem Cytochem 41:727-731 [Abstract/Free Full Text]

Squibb KS, Ridlington JW, Carmichael NG, Fowler BA (1979) Early cellular effects of circulating cadmium-thionein in kidney proximal tubules. Environ Health Perspect 28:287-296 [Medline]

Stillman MJ, Gasyna Z, Zelazowski AJ (1989) A luminescence probe for metallothionein in liver tissue: emission intensity measured directly from copper metallothionein induced in rat liver. FEBS Lett 257:283-286 [Medline]

Suzuki K, Nakajima K, Otaki K, Kimura M (1994) Metallothionein in developing human brain. Biol Signals 3:188-192 [Medline]

Suzuki-Kurasaki M, Kurasaki M, Kojima Y (1996) Low molecular weight copper-binding protein in the liver of rats given a single and repeated injections of copper. Res Commun Mol Pathol Pharmacol 92:299-314 [Medline]

Suzuki K, Nagara H (1981) Brindled Mottled mouse: morphological changes of brain and visceral organs in hemizygous males following copper supplementation. Acta Neuropathol (Berl) 55:251-255 [Medline]

Tohyama C, Suzuki JS, Hemelraad J, Nishimura N, Nishimura H (1993) Induction of metallothionein and its localization in the nucleus of rat hepatocytes after partial hepatectomy. Hepatology 18:1193-1201 [Medline]

Vulpe C, Levinson B, Whitney S, Packman S, Gitschier J (1993) Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nature Genet 3:7-13 [Medline]

Williams DM, Atkin CL (1981) Tissue copper concentrations of patients with Menkes kinky hair disease. Am J Dis Child 135:375-376

Williams LM, Cunningham H, Ghaffar A, Riddoch GI, Bremner I (1989) Metallothionein immunoreactivity in the liver and kidney of copper injected rats. Toxicology 55:307-316 [Medline]

Winge DR, Miklossy KA (1982) Domain nature of metallothionein. J Biol Chem 257:3471-3476 [Abstract/Free Full Text]

Yamaguchi Y, Heiny ME, Suzuki M, Gitlin JD (1996) Biochemical characterization and intracellular localization of the Menkes disease protein. Proc Natl Acad Sci USA 93:14030-14035 [Abstract/Free Full Text]